Skip to Main content Skip to Navigation
Theses

Système sérotoninergique 5-HT1A et schizophrénie : étude par tomographie par émission de positons au p-[18F]MPPF chez des patients schizophrènes traités par antipsychotiques

Abstract : Backgrounds: Multiple post-mortem and pharmacological studies suggest a key role of the serotonergic 1A (5-HT1A) system in the pathophysiology of schizophrenia. Materials and methods: The aim of our work was to assess the 5-HT1A receptors availability In patients suffering from schizophrenia treated with different antipsychotic drugs, compared to controls, using a new ligand antagonist of 5-HT1A receptors, the [18F]MPPF. The 5-HT1A binding potential of 19 schizophrenic patients (treated with either aripiprazole (a 5-HT1A partial agonist) or Second Generation Antipsychotic (olanzapine or risperidone) was compared with that of 19 age-matched healthy controls. This is the first report of a [18F]MPPF PET study in treated patients with schizophrenia. Results: A significant reduction of [18F]MPPF BPND was found in treated patients with schizophrenia compared to age- and gender-matched healthy subjects. These modifications were mainly localized in the frontal and orbitofrontal cortex and may reflect either the pathophysiology of schizophrenia or medication effects. In comparison to matched healthy subjects, the reduction of 5-HT1A receptor availability was more extensive in schizophrenic patients with aripiprazole treatment than in schizophrenic patients with SGA treatment. Conclusion: These results suggest that aripiprazole has a major impact on [18F]MPPF BPND, likely due to its partial agonist activity at 5-HT1A receptors. In order to distinguish the relative contributions of the disease itself versus medication effects, future [18F]MPPF studies should be performed in APD-naïve patients with schizophrenia
Document type :
Theses
Complete list of metadata

Cited literature [261 references]  Display  Hide  Download

https://hal.univ-lorraine.fr/tel-01746320
Contributor : Thèses Ul <>
Submitted on : Thursday, March 29, 2018 - 10:31:05 AM
Last modification on : Tuesday, October 13, 2020 - 10:45:47 AM
Long-term archiving on: : Thursday, September 13, 2018 - 11:56:00 AM

File

SCD_T_2011_0152_LEROND.pdf
Files produced by the author(s)

Identifiers

  • HAL Id : tel-01746320, version 1

Citation

Jérôme Lerond. Système sérotoninergique 5-HT1A et schizophrénie : étude par tomographie par émission de positons au p-[18F]MPPF chez des patients schizophrènes traités par antipsychotiques. Médecine humaine et pathologie. Université Henri Poincaré - Nancy 1, 2011. Français. ⟨NNT : 2011NAN10152⟩. ⟨tel-01746320⟩

Share

Metrics

Record views

127

Files downloads

1288